The products include prescription drugs to treat patients undergoing ocular interventions or suffering from infections or inflammatory diseases of the eye. In particular, the portfolio includes two artificial
This method of use patent covers the company’s Brisdelle (paroxetine) capsules, 7.5mg, for the treatment of moderate to severe vasomotor symptoms (VMS) associated with menopause, commonly referred to
The 28-month contract, a follow-on option to a contract begun in 2011, will include development of additional clinical supplies, regulatory filings and testing in two animal models to
Zorvolex was approved in October 2013 by the US Food and Drug Administration (FDA) for the treatment of mild to moderate acute pain in adults. Iroko president and
The most recent order for TapouT-branded products was for Go4ITNutrition.com. Go4ITNutrition is an online marketplace that deals specifically in sports supplements and sports nutrition products. The website features
The FDA Division of Anesthesia and Analgesia Products agreed to a 505(b) regulatory pathway to obtain market approval for the product. The company anticipates initiating the pivotal pharmacokinetic
This new patent provides broader intellectual property rights relating to compositions and methods of developing and producing novel enzymes which efficiently convert different sources of plant biomass (for
IBM’s Big Data analytics technologies will be put to work on bacterial genetics and drug susceptibility tests to better understand the genomic mechanisms that cause resistance to antibiotics.
Mylan previously sued Teva alleging that Teva’s Abbreviated New Drug Application (ANDA) for this product infringed four Mylan patents covering Perforomist. After a full trial, the Court entered
The Australian and Philippine patents have been allowed with a very broad range of claims to a large number of families of chemical structure compositions, pharmaceutical compositions, methods
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.